Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ethyl piperidinoacetylaminobenzoate
- Development stage
- Unknown
- Lead developer
- Nichi-Iko Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ethyl piperidinoacetylaminobenzoate is a small molecule local anesthetic primarily indicated for the symptomatic treatment of acute and chronic gastritis, as well as associated gastric pain, nausea, and discomfort. As a benzoate ester, it functions by exerting a local anesthetic effect on the gastric mucosa, thereby reducing sensitivity and alleviating pain. The compound is recognized as a Japanese Accepted Name (JAN) and is primarily marketed in Japan by companies such as Nichi-Iko Pharmaceutical. It is typically administered orally in tablet form.
- Brand names
- SulcainSulcaineNichicaine
- Other names
- Ethyl 4-(2-piperidinoacetylamino)benzoateEthyl p-(piperidinoacetylamino)benzoate
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on ethyl piperidinoacetylaminobenzoate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ethyl piperidinoacetylaminobenzoate.